iCAD (DeepHealth) vs Regard

iCAD develops AI-powered breast health solutions that help radiologists improve the early detection of breast cancer. Its ProFound Breast Health Suite uses deep learning to analyze mammograms, assess breast density, and identify suspicious findings. The platform is designed to increase diagnostic accuracy, reduce reading times, and optimize radiology workflows. iCAD solutions integrate with existing PACS and imaging systems and are used by hospitals, imaging centers, and breast screening programs worldwide. In 2025, iCAD was acquired by DeepHealth, a RadNet subsidiary, expanding DeepHealth's portfolio of AI-driven imaging technologies while retaining the iCAD brand.

Regard is an AI-powered clinical insights platform designed to help healthcare providers identify diagnoses and generate more complete clinical documentation. The platform analyzes patient records and surfaces relevant clinical findings at the point of care. It helps clinicians improve documentation accuracy, reduce administrative burden, and capture missed diagnoses. Regard reviews large amounts of patient data to provide actionable recommendations before and during patient visits. The platform is used by hospitals and health systems to improve care quality and operational performance. Its primary focus is proactive clinical decision support and documentation enhancement.